Project Samri Inc.
Biotechnology company · Boston, Massachusetts, United States
Project Samri Inc. is a biotechnology company headquartered in Boston, Massachusetts, United States. Its earliest recorded incorporation is in 2023. It has reported private securities offerings to the US SEC, most recently $11 million sold in a notice filed in 2023.
Project Samri at a glance
What does Project Samri do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $10.5 million sold (2023).
Frequently asked questions about Project Samri
Where is Project Samri headquartered?
Project Samri Inc. is headquartered in Boston, Massachusetts, United States.
What does Project Samri do?
Project Samri Inc. is a biotechnology company.
When was Project Samri founded?
The earliest incorporation on record for Project Samri Inc. is in 2023, according to public company registers.
Similar companies
- Syntis Bio, Inc.Boston, Massachusetts, United States
- Strand Therapeutics Inc.Boston, Massachusetts, United States
- Pear Therapeutics, Inc.Boston, Massachusetts, United States
- Aura Biosciences, Inc.Boston, Massachusetts, United States
- Holobiome, Inc.Boston, Massachusetts, United States
- Leuko Labs, Inc.Boston, Massachusetts, United States
- Compass Therapeutics, Inc.Boston, Massachusetts, United States
- Odyssey Therapeutics, Inc.Boston, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences